Autonomix Medical, Inc. has announced its plans to commence a follow-on phase of its proof-of-concept clinical trial, known as PoC 2, which is set to begin in Q2 2025. This phase will further evaluate ...
Atai Beckley (ATAI) announced topline results from the open-label extension study of its Phase 2b clinical trial of BPL-003 in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback